Trinity Biotech | TRIB - Ebitda

Aktienkurs
0.60
Täglich Wechseln
-0.03 -5.18%
Monatlich
-19.47%
Jährlich
-9.09%
Q1 Prognose
0.62




Ebitda Veränderung Datum
Abbott USD 3.09B 44M 2025-09
Bayer EUR 1.97B 457M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
EDAP TMS EUR -4.92M 843K 2025-09
J&J USD 9.52B 389M 2025-09
Mesa Laboratories USD 9.58M 1.47M 2024-09
OraSure Technologies USD -17.7M 4.06M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Siemens EUR 3.64B 535M 2025-12
Surmodics USD 1.53M 485K 2024-09
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Tosoh JPY 39.13B 286M 2024-12
Trinity Biotech USD -9.6M 7.64M 2024-12
Veracyte USD 42.31M 2.58M 2025-12